Thailand buys 50,000 courses of Pfizer anti-viral drug Paxlovid


BANGKOK (The Nation/Asia News Network): The Medical Services Department on Thursday (March 24) signed a contract to purchase 50,000 treatment courses of Paxlovid drug with Pfizer Thailand for Covid-19 patients in risk groups.

Department director-general Somsak Akkasilp took part in the online contract signing with Deborah Seifert, country manager of Pfizer Thailand and Indochina.

Subscribe to The Star Yearly Premium Plan for 30% off

Cancel anytime. Ad-free. Full access to Web and App.

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.39/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thailand , covid-19 , anti-viral , Pfizer , drug , paxlovid

Next In Aseanplus News

Marcos to discuss trade and security during US visit as tariffs loom
China expected to keep lending rates steady, focus turns to Politburo meet
Pop-up market celebrates royal birthday
MACC remands construction contract manager and others in RM180mil bribery probe
PM ready to explain addendum issue to Umno division leaders
Appointments show there's no meddling in judiciary, says PM
Vietnam outlines new financial reforms in bid for emerging market status
China issues safety warning for its nationals studying in the Philippines
Lightning strikes kill 33 people in eastern India
Billionaire scion pays US$19mil for Singapore bungalow

Others Also Read